A potential protein adjuvant derived from Mycobacterium tuberculosis Rv0652 enhances dendritic cells-based tumor immunotherapy.
Lee SJ, Shin SJ, Lee MH, Lee MG, Kang TH, Park WS, Soh BY, Park JH, Shin YK, Kim HW, Yun CH, Jung ID, Park YM.
Lee SJ, et al. Among authors: park jh, park ws, park ym.
PLoS One. 2014 Aug 7;9(8):e104351. doi: 10.1371/journal.pone.0104351. eCollection 2014.
PLoS One. 2014.
PMID: 25102137
Free PMC article.